3 Reasons BIIB is Risky and 1 Stock to Buy Instead
Shareholders of Biogen would probably like to forget the past six months even happened. The stock dropped 31.4% and now ...
Biogen (BIIB) Receives a Hold from Piper Sandler
In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...
Biogen Inc. (BIIB) CEO Chris Viehbacher presents at TD Cowen 45th Annual Health Care Conference (Transcript)
TD Cowen 45th Annual Health Care Conference March 3, 2025 9:10 AM ETCompany ParticipantsChris Viehbacher - CEOConference ...
4BIIB : What the Options Market Tells Us About Biogen
High-rolling investors have positioned themselves bullish on Biogen BIIB, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of ...
EU regulator reiterates positive recommendation for Eisai-Biogen's Alzheimer's drug
The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's Alzheimer's ...
Signs of hiring at Boston-area life sciences companies
Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...
Eisai, Biogen announce TGA of Australia declined approval of lecanemab
Eisai (ESAIY) and Biogen (BIIB) announced that the Therapeutic Goods Administration, TGA, of Australia has confirmed the initial decision to ...
Biogen Inc. (NASDAQ:BIIB) Stock Position Reduced by Private Advisor Group LLC
Private Advisor Group LLC trimmed its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 38.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...
Schaeffer's Investment Research2d
Stocks Plummet as Trade Partners Retaliate Against Tariffs
Stocks are freefalling this afternoon, as President Donald Trump's tariffs go into effect and trade partners retaliate ...